Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Luni Emdad

Showing results (131-140 of 164) with videos related to

Pageof 17
Sort By:
Oncotarget|October 14, 2015
Suppression of Her2/Neu mammary tumor development in mda-7/IL-24 transgenic miceYou-Jun Li, Guodong Liu, Lei Xia, et al.
Pharmacological Research|February 17, 2020
MDA-9/Syntenin (SDCBP): Novel gene and therapeutic target for cancer metastasisSwadesh K Das, Santanu Maji, Stephen L Wechman, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 21, 2010
Transcription factor Late SV40 Factor (LSF) functions as an oncogene in hepatocellular carcinomaByoung Kwon Yoo, Luni Emdad, Rachel Gredler, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|January 1, 2023
Retraction Notice to: Insulin-like Growth Factor-binding Protein-7 (IGFBP7): A Promising Gene Therapeutic for Hepatocellular Carcinoma (HCC)Dong Chen, Ayesha Siddiq, Luni Emdad, et al.
Cancer Research|December 13, 2012
MDA-9/syntenin and IGFBP-2 promote angiogenesis in human melanomaSwadesh K Das, Sujit K Bhutia, Belal Azab, et al.
Cancer Letters|June 22, 2020
Corrigendum to "Prevention of epithelial to mesenchymal transition in colorectal carcinoma by regulation of the E-cadherin-β-catenin-vinculin axis" [Cancer Lett. 452 (2019) 254-263]Ipsita Pal, Y Rajesh, Payel Banik, et al.
Molecular Cancer Therapeutics|February 19, 2008
Regulation of GST-MDA-7 toxicity in human glioblastoma cells by ERBB1, ERK1/2, PI3K, and JNK1-3 pathway signalingAdly Yacoub, Pankaj Gupta, Margaret A Park, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|January 16, 2013
RETRACTED: Insulin-like growth factor-binding protein-7 (IGFBP7): a promising gene therapeutic for hepatocellular carcinoma (HCC)Dong Chen, Ayesha Siddiq, Luni Emdad, et al.
Molecular Pharmaceutics|May 23, 2018
Targeting of EGFR, VEGFR2, and Akt by Engineered Dual Drug Encapsulated Mesoporous Silica-Gold Nanoclusters Sensitizes Tamoxifen-Resistant Breast CancerB N Prashanth Kumar, Nagaprasad Puvvada, Shashi Rajput, et al.
Biochimica Et Biophysica Acta. Molecular Basis of Disease|April 12, 2023
A novel computational predictive biological approach distinguishes Integrin β1 as a salient biomarker for breast cancer chemoresistanceSubhayan Das, Moumita Kundu, Atif Hassan, et al.
Pageof 17

Showing results (131-140 of 164) with videos related to

Sort By:
Pageof 17
Oncotarget|October 14, 2015
Suppression of Her2/Neu mammary tumor development in mda-7/IL-24 transgenic miceYou-Jun Li, Guodong Liu, Lei Xia, et al.
Pharmacological Research|February 17, 2020
MDA-9/Syntenin (SDCBP): Novel gene and therapeutic target for cancer metastasisSwadesh K Das, Santanu Maji, Stephen L Wechman, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 21, 2010
Transcription factor Late SV40 Factor (LSF) functions as an oncogene in hepatocellular carcinomaByoung Kwon Yoo, Luni Emdad, Rachel Gredler, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|January 1, 2023
Retraction Notice to: Insulin-like Growth Factor-binding Protein-7 (IGFBP7): A Promising Gene Therapeutic for Hepatocellular Carcinoma (HCC)Dong Chen, Ayesha Siddiq, Luni Emdad, et al.
Cancer Research|December 13, 2012
MDA-9/syntenin and IGFBP-2 promote angiogenesis in human melanomaSwadesh K Das, Sujit K Bhutia, Belal Azab, et al.
Cancer Letters|June 22, 2020
Corrigendum to "Prevention of epithelial to mesenchymal transition in colorectal carcinoma by regulation of the E-cadherin-β-catenin-vinculin axis" [Cancer Lett. 452 (2019) 254-263]Ipsita Pal, Y Rajesh, Payel Banik, et al.
Molecular Cancer Therapeutics|February 19, 2008
Regulation of GST-MDA-7 toxicity in human glioblastoma cells by ERBB1, ERK1/2, PI3K, and JNK1-3 pathway signalingAdly Yacoub, Pankaj Gupta, Margaret A Park, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|January 16, 2013
RETRACTED: Insulin-like growth factor-binding protein-7 (IGFBP7): a promising gene therapeutic for hepatocellular carcinoma (HCC)Dong Chen, Ayesha Siddiq, Luni Emdad, et al.
Molecular Pharmaceutics|May 23, 2018
Targeting of EGFR, VEGFR2, and Akt by Engineered Dual Drug Encapsulated Mesoporous Silica-Gold Nanoclusters Sensitizes Tamoxifen-Resistant Breast CancerB N Prashanth Kumar, Nagaprasad Puvvada, Shashi Rajput, et al.
Biochimica Et Biophysica Acta. Molecular Basis of Disease|April 12, 2023
A novel computational predictive biological approach distinguishes Integrin β1 as a salient biomarker for breast cancer chemoresistanceSubhayan Das, Moumita Kundu, Atif Hassan, et al.
Pageof 17